Precision AQ

Ross Maclean, MDExecutive Vice President, Partner

Ross Maclean, MD, is a global health economics and market access leader with 35+ years of experience in HEOR, health policy, and pharmaceutical strategy. He drives innovation and cross-functional collaboration at Precision AQ—advancing access, shaping value strategies, and aligning global healthcare systems to deliver meaningful patient outcomes.

Let's talk

Insights from Ross Maclean, MD

FDA Accelerated Approval: Implications For Treatment Innovation In Oncology Image

Commercialization & Access | Article FDA Accelerated Approval: Implications For Treatment Innovation In Oncology

AI-Powered Real-World Evidence Generation For Biotechs Image

Commercialization & Access | Article AI-Powered Real-World Evidence Generation For Biotechs

HEOR Value demonstration for Antibody-Drug Conjugates: Lessons learned from the first 25 years. Image

Commercialization & Access | Industry Brief HEOR Value demonstration for Antibody-Drug Conjugates: Lessons learned from the first 25 years.

The Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific Markets Image

Commercialization & Access | White Paper The Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific Markets See how looking beyond clinical value can strengthen your case with payers and policymakers.